Comprehensive review on natural pharmacophore tethered 1, 2, 3‐triazoles as active pharmaceuticals. (2nd October 2022)
- Record Type:
- Journal Article
- Title:
- Comprehensive review on natural pharmacophore tethered 1, 2, 3‐triazoles as active pharmaceuticals. (2nd October 2022)
- Main Title:
- Comprehensive review on natural pharmacophore tethered 1, 2, 3‐triazoles as active pharmaceuticals
- Authors:
- Rammohan, Aluru
Venkatesh, Bhumireddy Chinnachennaiahgari
Basha, Nabhubygari Mahaboob
Zyryanov, Grigory V.
Nageswararao, Mekala - Abstract:
- Abstract: The privileged 1, 2, 3‐triazole scaffold is drawing researcher's attention due to its widespread applications in diverse fields such as drug discovery (e.g., carboxyamidotriazole), organic synthesis (click‐reaction template), polymeric materials (e.g., triazolamer), supramolecular receptors (e.g., triazolophane), fluorescent materials (e.g., metal–organic frameworks), and agricultural sectors (e.g., fungicides). Various 1, 2, 3‐triazole persuasion modules are also currently available in the market that have multiple assets such as active pharmaceuticals and agricultural purposes. Owed to the highly consistent and firmest synthesis approach, that is, click reaction of various azides and acetylene derivatives by copper (I)‐catalyzed 1, 3‐dipolar cycloaddition (CuAAC), highly functionalized 1, 2, 3‐triazoles are prepared in scalar yields for drug discovery. Given the importance of 1, 2, 3‐triazole chemistry, the present review focuses specifically on the synthesis of structurally diverse 1, 2, 3‐triazoles linked to natural pharmacophores and their biological importance. Furthermore, the dual/multi‐pharmacophores assimilated 1, 2, 3‐triazoles have listed interesting biological activities that could be valuable as future drug leads. In addition, this comprehensive review can serve as a template for the development of new diverse scaffolds that will ensure for new therapeutic approaches for the existing myriad diseases and disorders. Abstract : The present review focusesAbstract: The privileged 1, 2, 3‐triazole scaffold is drawing researcher's attention due to its widespread applications in diverse fields such as drug discovery (e.g., carboxyamidotriazole), organic synthesis (click‐reaction template), polymeric materials (e.g., triazolamer), supramolecular receptors (e.g., triazolophane), fluorescent materials (e.g., metal–organic frameworks), and agricultural sectors (e.g., fungicides). Various 1, 2, 3‐triazole persuasion modules are also currently available in the market that have multiple assets such as active pharmaceuticals and agricultural purposes. Owed to the highly consistent and firmest synthesis approach, that is, click reaction of various azides and acetylene derivatives by copper (I)‐catalyzed 1, 3‐dipolar cycloaddition (CuAAC), highly functionalized 1, 2, 3‐triazoles are prepared in scalar yields for drug discovery. Given the importance of 1, 2, 3‐triazole chemistry, the present review focuses specifically on the synthesis of structurally diverse 1, 2, 3‐triazoles linked to natural pharmacophores and their biological importance. Furthermore, the dual/multi‐pharmacophores assimilated 1, 2, 3‐triazoles have listed interesting biological activities that could be valuable as future drug leads. In addition, this comprehensive review can serve as a template for the development of new diverse scaffolds that will ensure for new therapeutic approaches for the existing myriad diseases and disorders. Abstract : The present review focuses principally on the facile synthesis of various natural credible chromophore cohesive 1, 2, 3‐triazoles. Further, the appraisal pharmacological prominences of dual/multi‐pharmacophore triazole hybrids constructive to evaluate imminent drug developments. Delineated synthetic approaches of functionalized 1, 2, 3‐triazoles assimilated with various natural scaffolds shown credible bioactivities like anticancer, antiviral, and anti‐AD. … (more)
- Is Part Of:
- Chemical biology & drug design. Volume 101:Number 5(2023)
- Journal:
- Chemical biology & drug design
- Issue:
- Volume 101:Number 5(2023)
- Issue Display:
- Volume 101, Issue 5 (2023)
- Year:
- 2023
- Volume:
- 101
- Issue:
- 5
- Issue Sort Value:
- 2023-0101-0005-0000
- Page Start:
- 1181
- Page End:
- 1203
- Publication Date:
- 2022-10-02
- Subjects:
- 1, 2, 3‐triazoles -- Alzheimer disease (AD) -- azides -- chromenone -- click reaction -- nucleosides -- tacrine
Drugs -- Design -- Periodicals
Pharmaceutical chemistry -- Periodicals
Biochemistry -- Periodicals
615.19005 - Journal URLs:
- http://gateway.ovid.com/ovidweb.cgi?T=JS&MODE=ovid&NEWS=n&PAGE=toc&D=ovft&AN=01253034-000000000-00000 ↗
http://onlinelibrary.wiley.com/journal/10.1111/(ISSN)1747-0285 ↗
http://www.blackwell-synergy.com/loi/jpp ↗
http://onlinelibrary.wiley.com/ ↗ - DOI:
- 10.1111/cbdd.14148 ↗
- Languages:
- English
- ISSNs:
- 1747-0277
- Deposit Type:
- Legaldeposit
- View Content:
- Available online (eLD content is only available in our Reading Rooms) ↗
- Physical Locations:
- British Library DSC - 3139.120000
British Library DSC - BLDSS-3PM
British Library STI - ELD Digital store - Ingest File:
- 26885.xml